ELECTRICAL CARDIOVERSION IN OUTPATIENT CONDITIONS, HOSPITALIZATION REPLACEMENT TECHNOLOGY
https://doi.org/10.18705/2311-4495-2016-3-6-6-14
Abstract
Objective. Comparative evaluation of the efficacy, safety and cost-effectiveness of electrical cardioversion in patients with persistent form of atrial fibrillation in outpatient and hospital treatment.
Design and Methods. The study involved 140 patients with persistent form of atrial fibrillation in accordance with the inclusion / exclusion criteria: electrical cardioversion was performed on an outpatient basis in 108 patients , 32 patients received electrical cardioversion(ECV) on hospital treatment. All patients had ECG, which was performed at admission and 10 days after ECV. All patients were prospectively monitoring for long-term efficacy and safety of antiarrhythmic therapy. Results of the study were processed by methods of variation statistics. Cost-effectiveness analysis was calculated taking into account the factor of «cost / benefit».
Results and conclusions. The efficacy and safety of ECV in outpatient are no different from the ECV in hospital. Performing ECV in outpatient conditions is 6 times cheaper than in the hospital.
About the Authors
S. V. Buzyuk
Regional Clinical Hospital №2
Russian Federation
Russian Federation
Svetlana V. Buzyuk.
Krasnodar
V. R. Berngardt
Federal Almazov North-West Medical Research Centre
Russian Federation
Russian Federation
Edward R. Berngardt - PhD, senior researcher officer of electrocardiological laboratory.
Akkuratova str. 2, Saint Petersburg, 197341, e-mail: edbern@mail.ru
V. K. Zafiraki
Kuban State Medical University
Russian Federation
Russian Federation
Vitaly K. Zafiraki - docent.
Krasnodar
N. V. Kizhvatova
Kuban State Medical University
Russian Federation
Russian Federation
Natalia V. Kizhvatova - PhD.
Krasnodar
References
1. Nedostup AV, Sirkin AL, Maevskaya IV. Cardioversion of atrial fibrillation. 1998: 83-126.In Russian [Недоступ А.В., Сыркин А.Л., Маевская И.В. Электроимпульсная терапия мерцательной аритмии. 1998: 83–126].
2. Baily D, Lehmann MH, Schumacher DN et al. Hospitalization for arrhythmias in the United States: importance of atrial fibrillation. Am J Cardiol. 1992; 19:14A.
3. Benjamin EJ, Wolf PA, D’Agostino et al. Impact of atrial fibrillation on the risk of death. the Framingham Heart study. Circulation. 1998; 98:946-952.
4. Kerr C, Boone J, Connolly S et al. Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation. Eur Heart J. 1996; 17( Suppl C): S48-51.
5. Bhatia A, Sra J. Atrial fibrillation: epidemiology, mechanisms and management. Indian Heart J. 2000; 52(2):129–164.
6. Alboni P, Botto GL, Baldi N et al. Outpatient treatment of recent-onset atrial fibrillation with the “pill-inthe-pocket” approach. N Engl J Med. 2004; 351(23): 2384-91.
7. Kadyrov FN. Economic methods of assessing the effectiveness of health care. Moskva. Menedger zdravoochraneniya, 2007. p. 74. In Russian [Кадыров Ф.Н. Экономические методы оценки эффективности деятельности медицинских учреждений. Москва. Менеджер здравоохранения, 2007. c. 74].
8. Istomin TA, Serdechnaya EV, Kulminskaya LA et al. Efficacy and safety of sinus rhythm with amiodarone and propafenone on an outpatient basis, economic aspects. Rational pharmacotherapy in cardiology. 2010; 6: 45-51. In Russian [Истомина Т.А., Сердечная Е.В., Кульминская Л.А. и др. Эффективность и безопасность восстановления синусового ритма амиодароном и пропафеноном в амбулаторных условиях, экономические аспекты. Рациональная фармакотерапия в кардиологии. 2010;6: 45–51].
9. Kanorsky SG, Bodrikova VV, Kanorskaya YS. Antirecurrent effect of anti-drugs with anti-inflammatory activity in patients with paroxysmal atrial fibrillation: myth or reality? Journal of arrhythmology=Vestnik aritmologii. 2007; 48: 22-27. In Russian [Канорский С.Г., Бодрикова В.В. Канорская Ю.С. Противорецидивный эффект препаратов с противовоспалительной активностью у больных с пароксизмальной фибрилляцией предсердий: миф или реальность? Вестник аритмологии. 2007;48: 22-27].
10. Vostrikov VA, Holine PV, Razumov KV et al. The effectiveness of electrical cardioversion of paroxysmal atrial fibrillation. Abstracts of the VIII International Slavic Congress on electrostimulation and clinical electrophysiology of heart “CARDIOSTIM” February 14-16, 2008, St. Petersburg. Journal of arrhythmology=Vestnik aritmologii. 2008; 44(Suppl A,С): S47. In Russian [Востриков В.А., Холин П.В., Разумов К.В. и др. Эффективность электрической кардиоверсии пароксизмальной фибрилляции предсердий. Тезисы докладов VIII Международного славянского конгресса по электростимуляции и клинической электрофизиологии сердца «КАРДИОСТИМ» 14-16 февраля 2008, Санкт-Петербург, Вестник аритмологии, 2008; 44: 47 приложение А, С].
11. Eremenko ED, Egorova EA, Sokolova LA. Hypertensive myocardial remodeling as a risk factor in the development of atrial fibrillation in hypertensive patients. Journal of arrhythmology=Vestnik aritmologii. 2011; 64: 38-43. In Russian [Еременко Е.Д., Егорова Е.А. Соколова Л.А. Гипертоническое ремоделирование миокарда как фактор риска развития фибрилляции предсердий у пациентов с артериальной гипертензией. Вестник аритмологии. 2011; 64: 38-43].
12. Miller ON, Bakhmeteva TA. Causality occurrence of atrial fibrillation in patients with arterial hypertension. Journal of arrhythmology=Vestnik aritmologii. 2006; 44: 44-48. In Russian [Миллер О.Н., Бахметьева Т.А. Причинно-следственные связи возникновения фибрилляции предсердий у больных артериальной гипертензией. Вестник аритмологии. 2006;44: 44-48].
13. Bokeria LA, Kovalev SA, Filatov AG et al. Treatment of atrial fibrillation: Data from randomized trials. Journal of Experimental and Clinical Surgery=Vestnik of experimental and clinical surgery. 2012; 2: 447-462. In Russian [Бокерия Л.А., Ковалев С.А., Филатов А.Г. и др. Лечение фибрилляции предсердий: данные рандомизированных исследований. Вестник экспериментальной и клинической хирургии. 2012; 2: 447–462].
14. Dankner R, Shahar A, Novikov I et al. Treatment of stable atrial fibrillation in the emergency department: a population-based comparison of electrical direct-current versus pharmacological cardioversion or conservative management. Cardiology. 2009; 112(4):270-278.
Review
For citations:
Buzyuk S.V., Berngardt V.R., Zafiraki V.K., Kizhvatova N.V. ELECTRICAL CARDIOVERSION IN OUTPATIENT CONDITIONS, HOSPITALIZATION REPLACEMENT TECHNOLOGY. Translational Medicine. 2016;3(6):6-14. (In Russ.) https://doi.org/10.18705/2311-4495-2016-3-6-6-14
Views:
1492
Email this article 